Jane Freeman

6.0k total citations · 1 hit paper
102 papers, 4.2k citations indexed

About

Jane Freeman is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Jane Freeman has authored 102 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Infectious Diseases, 52 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in Jane Freeman's work include Clostridium difficile and Clostridium perfringens research (70 papers), Microscopic Colitis (38 papers) and Viral gastroenteritis research and epidemiology (30 papers). Jane Freeman is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (70 papers), Microscopic Colitis (38 papers) and Viral gastroenteritis research and epidemiology (30 papers). Jane Freeman collaborates with scholars based in United Kingdom, United States and New Zealand. Jane Freeman's co-authors include Mark H. Wilcox, Simon D. Baines, Warren N. Fawley, Ed J. Kuijper, S. L. Todhunter, C. H. Chilton, Martijn P. Bauer, Jeroen Corver, Abraham Goorhuis and Jon J. Vernon and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Jane Freeman

98 papers receiving 4.1k citations

Hit Papers

The Changing Epidemiology... 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Changing Epidemiology of Clostridium difficile Infections
    2010 641 citations Jane Freeman, Simon D. Baines et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jane Freeman 3.4k 2.1k 794 683 509 102 4.2k
Arnold Lentnek 2.4k 0.7× 1.9k 0.9× 603 0.8× 323 0.5× 347 0.7× 36 3.3k
D. W. Burdon 1.4k 0.4× 977 0.5× 1.2k 1.5× 425 0.6× 224 0.4× 82 3.2k
Sahil Khanna 4.3k 1.3× 3.3k 1.5× 1.4k 1.7× 1.9k 2.8× 601 1.2× 270 6.5k
Ian F. Laurenson 1.2k 0.4× 1.9k 0.9× 620 0.8× 234 0.3× 398 0.8× 78 3.0k
Wolfgang Graninger 802 0.2× 826 0.4× 484 0.6× 405 0.6× 231 0.5× 105 2.8k
Christoph Wenisch 1.0k 0.3× 1.0k 0.5× 279 0.4× 383 0.6× 361 0.7× 143 3.4k
Stefano Di Bella 921 0.3× 719 0.3× 300 0.4× 367 0.5× 226 0.4× 142 2.3k
John N. Sheagren 1.2k 0.4× 980 0.5× 465 0.6× 455 0.7× 272 0.5× 81 3.0k
Colleen Kelly 4.1k 1.2× 2.4k 1.1× 1.2k 1.5× 2.8k 4.0× 224 0.4× 112 5.8k
Gülşen Hasçelik 608 0.2× 758 0.4× 527 0.7× 413 0.6× 67 0.1× 165 2.6k

Countries citing papers authored by Jane Freeman

Since Specialization
Citations

This map shows the geographic impact of Jane Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Freeman more than expected).

Fields of papers citing papers by Jane Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Freeman. The network helps show where Jane Freeman may publish in the future.

Co-authorship network of co-authors of Jane Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Freeman. A scholar is included among the top collaborators of Jane Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Freeman. Jane Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vernon, Jon J., David W. Eyre, M. H. Wilcox, & Jane Freeman. (2025). Molecular clock complexities of Clostridioides difficile. Anaerobe. 93. 102953–102953. 1 indexed citations
2.
3.
Chilton, C. H., Virginie Viprey, Inês B. Moura, et al.. (2025). Clostridioides difficile pathogenesis and control. Nature Reviews Microbiology. 24(3). 215–232. 1 indexed citations
4.
Freeman, Jane, Virginie Viprey, Emma Clark, et al.. (2024). Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance. 6(4). dlae112–dlae112. 1 indexed citations
5.
Strawbridge, Judith, John Heritage, Marcela Krůtová, et al.. (2023). Hear my voice: involving patients in Clostridioides difficile infection research. Clinical Microbiology and Infection. 29(10). 1222–1224. 1 indexed citations
6.
Dingle, Kate E., Jane Freeman, Xavier Didelot, et al.. (2023). Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile. mBio. 14(2). e0024323–e0024323. 9 indexed citations
7.
Greetham, Darren, Michael P. Williamson, Caroline A. Evans, et al.. (2023). Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance. Journal of Biological Chemistry. 300(1). 105529–105529. 6 indexed citations
8.
Marchandin, Hélène, Gaëtan Poulen, Jane Freeman, et al.. (2023). In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile. Journal of Antimicrobial Chemotherapy. 78(8). 1992–1999. 26 indexed citations
9.
Rodríguez, César, Céline Harmanus, Ingrid M. J. G. Sanders, et al.. (2023). Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model. Antibiotics. 12(3). 435–435. 5 indexed citations
10.
Chilton, C. H. & Jane Freeman. (2015). Predictive Values of Models of Clostridium difficile Infection. Infectious Disease Clinics of North America. 29(1). 163–177. 4 indexed citations
11.
Freeman, Jane, Jon J. Vernon, K. Morris, et al.. (2014). Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clinical Microbiology and Infection. 21(3). 248.e9–248.e16. 217 indexed citations
12.
Crowther, G. S., C. H. Chilton, S. L. Todhunter, et al.. (2014). Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota. PLoS ONE. 9(2). e88396–e88396. 39 indexed citations
13.
Chilton, C. H., G. S. Crowther, Jane Freeman, et al.. (2013). Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure. Journal of Antimicrobial Chemotherapy. 69(2). 451–462. 41 indexed citations
14.
Chilton, C. H., Jane Freeman, G. S. Crowther, S. L. Todhunter, & Mark H. Wilcox. (2012). Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model. Journal of Antimicrobial Chemotherapy. 67(10). 2434–2437. 25 indexed citations
15.
Freeman, Jane, et al.. (2012). Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: Association with distinct demographic groups in the community in New Zealand. European Journal of Clinical Microbiology & Infectious Diseases. 31(8). 2057–2060. 12 indexed citations
16.
Baines, Simon D., Rory J O’Connor, Katherine Saxton, Jane Freeman, & Mark H. Wilcox. (2008). Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model. Journal of Antimicrobial Chemotherapy. 62(5). 1078–1085. 47 indexed citations
17.
Baines, Simon D., Jane Freeman, Warren N. Fawley, et al.. (2008). Emergence of reduced susceptibility to metronidazole in Clostridium difficile. Journal of Antimicrobial Chemotherapy. 62(5). 1046–1052. 207 indexed citations
18.
Baines, Simon D., Katherine Saxton, Jane Freeman, & Mark H. Wilcox. (2006). Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model. Journal of Antimicrobial Chemotherapy. 58(5). 1062–1065. 67 indexed citations
19.
Jiwa, Moyez, et al.. (2005). Factors that impact on the application of guidelines in general practice: a review of medical records and structured investigation of clinical incidents in hypertension. Quality in primary care. 13(4). 215–222. 2 indexed citations
20.
Roberts, John M. & Jane Freeman. (1983). Entry to general practice training.. BMJ. 287(6406). 1677–1679. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnold Lentnek Breakdown of academic impact, for papers by D. W. Burdon Breakdown of academic impact, for papers by Sahil Khanna Breakdown of academic impact, for papers by Ian F. Laurenson Breakdown of academic impact, for papers by Wolfgang Graninger Breakdown of academic impact, for papers by Christoph Wenisch Breakdown of academic impact, for papers by Stefano Di Bella Breakdown of academic impact, for papers by John N. Sheagren Breakdown of academic impact, for papers by Colleen Kelly Breakdown of academic impact, for papers by Gülşen Hasçelik
Rankless by CCL
2026